[March 28, 2017]

Global Antifungal Drugs Market 2017-2021: Key Vendors are Pfizer, Merck, Astellas Pharma, Novartis & Johnson & Johnson - Research and Markets

Research and Markets has announced the addition of the "Global Antifungal Drugs Market 2017-2021" report to their offering.

The global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021.

Antifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption.

The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period. The report also includes a discussion of the Key vendors operating in this market.

Market Dynamics

Market drivers

• QIDP and other special regulatory designations
• Increase in prevalence of infections and environmental changes
• Rising popularity of OTC antifungal drugs for dermal infections
  
  
  
  

Market challenges

• Antifungal drug resistance
• Increased availability of generics and alternative therapies
• Poor patient adherence
  

Market trends

• Increased funding for antifungal research
• Increased focus on combination therapies
• Incorporation of novel technology for product development
• Strategic alliances and M&A

Key vendors

• Pfizer
• Merck
• Astellas Pharma
• Novartis
• Johnson & Johnson

Other prominent vendors

• Allergan
• Almirall
• Amgen
• Aqua Pharmaceuticals
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Dermira
• Elorac
• F. Hoffmann-La Roche
• Galderma
• Genentech
• GlaxoSmithKline
• Hexima
• Hisamitsu Pharmaceutical
• Incyte
• Mayne Pharma
• MediQuest Therapeutics
• Meiji Seika Pharma
• Merz Pharmaceuticals
• Moberg Pharma
• Mylan Pharmaceuticals
• NanoBio
• NovaBiotics
• Novan
• Promius Pharma
• Sanofi
• Seren Pharmaceuticals
• Sun Pharma
• Taro
• Teva Pharmaceutical
• Theravance Biopharma
• Topica Pharmaceuticals
• Viamet Pharmaceuticals

For more information about this report visit http://www.researchandmarkets.com/research/g8h9qt/global_antifungal

View source version on businesswire.com: http://www.businesswire.com/news/home/20170328006225/en/

[ Back To TMCnet.com's Homepage ]